EDAP TMS S.A. (EDAP)
2.12
-0.10 (-4.50%)
At close: Mar 28, 2025, 3:59 PM
1.98
-6.60%
After-hours: Mar 28, 2025, 06:59 PM EDT
-4.50% (1D)
| Bid | 1.85 |
| Market Cap | 78.66M |
| Revenue (ttm) | 62.78M |
| Net Income (ttm) | -21.94M |
| EPS (ttm) | -0.64 |
| PE Ratio (ttm) | -3.31 |
| Forward PE | -4.49 |
| Analyst | Buy |
| Ask | 2.37 |
| Volume | 142,281 |
| Avg. Volume (20D) | 89,335 |
| Open | 2.29 |
| Previous Close | 2.22 |
| Day's Range | 2.05 - 2.43 |
| 52-Week Range | 1.96 - 8.50 |
| Beta | 0.37 |
About EDAP
EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST). The HIFU segment develops, manufactures, and ma...
Industry Medical - Devices
Sector Healthcare
IPO Date Aug 1, 1997
Employees 307
Stock Exchange NASDAQ
Ticker Symbol EDAP
Website https://www.edap-tms.com
Analyst Forecast
According to 2 analyst ratings, the average rating for EDAP stock is "Buy." The 12-month stock price forecast is $11.75, which is an increase of 454.25% from the latest price.
Stock ForecastsEarnings Surprise
EDAP TMS S.A. has released their quartely earnings
on Mar 27, 2025:
2 days ago
+8.29%
EDAP TMS shares are trading higher after the compa...
Unlock content with
Pro Subscription
7 months ago
+4.18%
EDAP TMS shares are trading higher after the company reported better-than-expected Q2 revenue results.
